Unless otherwise specified herein, manuscripts should conform to the templates provided on the conference website.

The authors may be asked to provide further information for editorial review; they should be prepared to provide public access to any relevant data, unless its content is restricted, and should in any event be prepared to retain such data for a reasonable time after publication.

The authors should ensure that their work is original, and acknowledge in an appropriate manner any work of other authors, contributors or sources (including online sources), correspondence and discussion with third parties. All those who have made significant contributions should be listed as co-authors. Plagiarism constitutes unethical publishing behaviour and is unacceptable.

Multiple, concurrent or redundant manuscript submission for publication constitutes unethical publishing behaviour and is unacceptable.

All authors should disclose in their manuscript any conflict of interest that might be construed to influence the results or interpretation of their conclusion. All sources of financial support should be appropriately disclosed.

Manuscripts will be evaluated for the quality and the originality of their content only, without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. The editors’ final decision to accept or reject an abstract for publishing is based on the reviewer’s comments, and on the relevance of the abstract to the remit of these proceedings.

Reviewers assist the editors in making editorial decisions and may also assist the authors in improving their manuscripts. Reviews should be conducted objectively and personal criticism of the authors is inappropriate. The editors, any editorial staff and reviewers must not disclose any information about a submitted manuscript to anyone other than the corresponding authors, reviewers, and the publisher, as appropriate. The editors ensure that the peer review process is fair and unbiaised, and are ready to respond to any complaint.

Unpublished materials received via a manuscript submission must not be used in an editor’s own research or in any editorial staff and reviewers’ own research, without the express written consent of the authors; and any information obtained through peer review must be kept confidential.

Editors should not themselves consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors or institutions connected to them.

Editors should take immediate responsive measures when ethical complaints have been presented. If concerns are raised about a possible misconduct, and where applicable, the editors will follow COPE flowcharts and make all reasonable efforts to ensure that the proper enquiries are made.

Presentation Format Overview

  • The total time allotted for regular presentation is a maximum of 15 minutes: this is ideally broken down into a recommended split of 10–12 minutes for the core presentation and 3–5 minutes reserved for the Q&A session.
  • The official delivery language for all slides and spoken commentary is English.


Pre-Session & Arrival Protocol

  • Arrive Early: You must arrive at your presentation room at least 10 minutes before the session block begins, rather than right before your individual slot.
  • Notify the Session Chair: Locate the Session Chair or Mini-Symposia Organizer immediately upon arrival to inform them that you are present, confirm the pronunciation of your name, and ensure your presentation slides are pre-loaded and rendering correctly.
  • Ethics Check: Take a moment to verify that your final slides align strictly with what was approved in your peer-reviewed abstract, ensuring complete transparency.


Presentation Structure & Content Guidelines

Your presentation must reflect the flow of a highly rigorous, peer-reviewed scientific abstract. As a generic guideline, ensure your slide deck covers the following aspects:

  • Title & Author Affiliations: Include the clear, comprehensive title of your work, list all co-authors who made significant contributions, and explicitly include any disclosures or conflicts of interest at the bottom of this slide.
  • Background & Research Objectives: Provide a brief introductory context highlighting a topic of substantial current interest within computational biomedicine, and clearly state the core hypotheses and objectives of your study.
  • Methodology & Experimental Procedures: Outline the pertinent experimental, mathematical, or computational procedures used. If AI or AI-assisted technologies were used to generate data or models, ensure this is transparently documented in this section.
  • Results, Data Summary, & Figures: Present an overview of your recent and original work using clear data, figures, or charts that are easy to read from the back of the room, keeping formatting standard and unaltered.
  • Conclusions & Future Work: Deliver a final, objective statement summarizing the conclusions drawn from your data, and explicitly state how this research adds to the body of knowledge in the field.


Delivery & Q&A Protocol

  • Maintain Strict Objectivity: In accordance with standard reviewing ethics, present your work objectively, keeping in mind that personal criticisms of competing methodologies or other authors’ works are entirely inappropriate.
  • Respect the Clock: Do not exceed your allotted time, and be prepared for the session chair to give you a warning when you have 2 minutes remaining so as not to disrupt the global conference schedule.
  • Managing the Q&A Session: Welcome questions from the audience and the session organizers, responding to feedback constructively to assist in improving the manuscript for its eventual inclusion in the official conference proceedings.


Post-Presentation Responsibilities

  • Be prepared to retain your relevant presentation data and public access details for a reasonable time after the conference, as editorial boards or peers may follow up with inquiries regarding your methodology or results.
  • The authors should ensure that their work is original, and acknowledge in an appropriate manner any work of other authors, contributors or sources (including online sources), correspondence and discussion with third parties. All those who have made significant contributions should be listed as co-authors. Plagiarism constitutes unethical publishing behaviour and is unacceptable.
  • All authors should disclose in their manuscript any conflict of interest that might be construed to influence the results or interpretation of their conclusion. All sources of financial support should be appropriately disclosed.

The integrity, flow, and success of the CMBE sessions rely heavily on the proactive leadership of the Session Chair. In accordance with publishing and conference policies, your primary directive is to ensure objective delivery, foster constructive scholarly dialogue, and strictly enforce the schedule. Maintaining exact timing is of critical importance – delaying a session disrupts the entire global conference schedule, impact the subsequent presenters, and audience schedules.


Session Timing and Structure Matrices

There are four distinct presentation formats during this conference. Ensure that you stick to the exact timing AND brief each speaker on their exact time boundaries before the session begins.

  • Regular Talks (15 Minutes Total) – Presentation Delivery: The speaker is allocated exactly 12 minutes for their core presentation. Question and Answer Split: You must reserve exactly 3 minutes for audience questions and the transition to the next speaker. Enforcement Action: Introduce the speaker promptly and give a clear visual signal at the 10-minute mark (2 minutes remaining for delivery).
  • Invited Session Keynotes (30 Minutes Total) – Presentation Delivery: The speaker is allocated 25 minutes to present their featured research. Question and Answer Split: You must reserve exactly 5 minutes for a structured Q&A session and technical transition. Enforcement Action: Provide a visual warning at 20 minutes (5 minutes remaining for delivery) and stand up at 25 minutes to transition to questions.
  • Keynote Talks (40 Minutes Total) – Presentation Delivery: The headline speaker is allocated 32 minutes for their presentation. Question and Answer Split: You must reserve exactly 8 minutes for an in-depth audience Q&A session. Enforcement Action: Signal the speaker at 30 minutes, allowing them 2 minutes to conclude their remarks smoothly before the discussion opens.
  • Plenary and Opening Talks (50 Minutes Total) – Presentation Delivery: The presenter is allocated 40 minutes for the main address. Question and Answer Split: You must reserve exactly 10 minutes for a comprehensive high-level discussion and audience engagement. Enforcement Action: Provide a subtle warning at 35 minutes and a firm signal at 40 minutes to ensure the critical Q&A period is not truncated.


Operational Protocol for Session Chairs

Pre-Session Preparation

Arrive Early: You must arrive at the presentation room at least 15 minutes prior to the start of the entire session block to meet your speakers.

Speaker and Bio Check: Verify that all scheduled presenters are present in the room, confirm the pronunciation of their names and affiliations, and ensure their slides are pre-loaded and rendering correctly.

Review Disclosures: Remind presenters that they must display any disclosures or financial conflicts of interest on their opening slides, in alignment with CMBE ethical guidelines.


Active Time Management

Monitor the Clock Constantly: Do not rely on the speaker to track their own time; you are the sole custodian of the session clock.

Use Clear Visual Signals: Agree with the speakers beforehand on how you will signal them (e.g., holding up a card or raising a hand) when they reach their warning threshold and when their speaking time has completely expired.

Immediate Intervention: If a speaker continues talking past their allotted delivery time, you must politely but firmly interrupt them, step to the podium, and transition directly into the Q&A or the next presentation.


Managing the Dialogue and Integrity

Maintain Strict Objectivity: Ensure that both the presentations and the subsequent Q&A sessions are conducted with professional objectivity, immediately intervening if any personal criticisms or inappropriate commercial promotions arise.

Facilitate Discussion: If the audience is slow to ask questions during the allocated Q&A split, you should be prepared to ask a relevant, constructive question yourself to stimulate academic dialogue.

Handle No-Shows Professionally: If a scheduled speaker fails to appear, do not advance the schedule; instead, utilize the empty 15-minute block for an extended panel discussion or a temporary recess, ensuring the next speaker begins exactly at their publicly advertised time slot.